1 / 8

Embolotherapy Market is expected to grow US$ 5,758.28 million by 2028

The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028. <br><br>for more click here..<br>https://www.theinsightpartners.com/reports/embolotherapy-market/?utm_source=freeplatform&utm_medium=10726

Sanket15
Download Presentation

Embolotherapy Market is expected to grow US$ 5,758.28 million by 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Embolotherapy Market Global Analysis and Forecast to 2028 Published Date : Aug 2022 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological & Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

  3. Email:sales@theinsightpartners.com Embolotherapy Market Value CAGR of 8.1% (2022 - 2028)

  4. Email:sales@theinsightpartners.com Embolotherapy Market Overview • The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028. • Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils, or gel foam using an angiographic catheter. The catheter aids in blocking a blood vessel by implanting a balloon or any foreign body to treat bleeding ulcers, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defects, or control inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery. • The embolotherapy market is segmented into product, disease indication, procedure end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market with an emphasis on parameters such as market trends and market dynamics, and the competitive analysis of the globally leading market players.

  5. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Product (Embolic Agent and Support Device) • By Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological & Nephrological Disorder, Gastrointestinal Disorder, and Other) • By Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)) • By End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

  6. Email:sales@theinsightpartners.com Company Profiles • Abbott • Boston Scientific Corporation • Cook Medical LLC • Johnson & Johnson • Medtronic • Acandis GmbH • SSEM Mthembu Medical (Pty) Ltd • Balt USA LLC • Stryker • Guerbet LLC • Terumo Corporation Download Sample Here

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related